Sinopharm Group Co. Ltd (X2S) — Working Capital to Net Assets Ratio
Sinopharm Group Co. Ltd (X2S) has a Working Capital to Net Assets ratio of 74.6% as of December 2025. Working capital of €100.07 Billion (current assets of €346.80 Billion minus current liabilities of €246.73 Billion) is measured against net assets of €134.16 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how financially flexible is Sinopharm Group Co. Ltd to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Sinopharm Group Co. Ltd Working Capital to Net Assets (2013–2025)
This chart shows how Sinopharm Group Co. Ltd's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the ratio stands at 74.6%, reflecting working capital of €100.07 Billion against net assets of €134.16 Billion EUR. See Sinopharm Group Co. Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Sinopharm Group Co. Ltd (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Sinopharm Group Co. Ltd from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see X2S market cap.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 74.6% | €100.07 Billion | €134.16 Billion | €346.80 Billion | €246.73 Billion | ▼ -2.0 pp |
| 2024 | 76.6% | €97.07 Billion | €126.69 Billion | €347.45 Billion | €250.38 Billion | ▼ -2.6 pp |
| 2023 | 79.2% | €95.34 Billion | €120.32 Billion | €336.84 Billion | €241.49 Billion | ▲ +2.5 pp |
| 2022 | 76.7% | €84.44 Billion | €110.07 Billion | €319.41 Billion | €234.96 Billion | ▲ +4.9 pp |
| 2021 | 71.9% | €71.62 Billion | €99.65 Billion | €290.92 Billion | €219.31 Billion | ▲ +1.1 pp |
| 2020 | 70.7% | €63.63 Billion | €89.95 Billion | €267.61 Billion | €203.98 Billion | ▲ +3.7 pp |
| 2019 | 67.0% | €51.58 Billion | €76.94 Billion | €230.00 Billion | €178.42 Billion | ▲ +1.7 pp |
| 2018 | 65.3% | €44.58 Billion | €68.28 Billion | €204.65 Billion | €160.07 Billion | ▼ -9.2 pp |
| 2017 | 74.5% | €38.19 Billion | €51.27 Billion | €162.77 Billion | €124.58 Billion | ▲ +0.3 pp |
| 2016 | 74.2% | €33.02 Billion | €44.53 Billion | €132.76 Billion | €99.74 Billion | ▲ +19.7 pp |
| 2015 | 54.5% | €22.28 Billion | €40.88 Billion | €117.90 Billion | €95.62 Billion | ▼ -12.3 pp |
| 2014 | 66.8% | €24.25 Billion | €36.29 Billion | €110.27 Billion | €86.02 Billion | ▲ +0.9 pp |
| 2013 | 66.0% | €18.87 Billion | €28.61 Billion | €89.71 Billion | €70.84 Billion | — |